Investor Relations

Vivos Therapeutics, Inc. NASDAQ: VVOS

Vivos Therapeutics, Inc. Annual Shareholder Meeting

September 22, 2023

4:00 EST/ 2:00 MST

Download Vivos Therapeutics, Inc. 2023 Annual Report

An Important Breakthrough in the Treatment for Mild-to-Moderate Obstructive Sleep Apnea

Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial abnormalities and/or mild-to-moderate OSA. This revolutionary treatment is called The Vivos Method.
Blobs Dentist

Latest Stock Information

Investor Presentation

Download the Vivos Investor Presentation

Download Now
IR Presentation cover

Please Listen to Our Q2 2023 Financial Results Conference Call here at 6:00PM EDT Wednesday, August 16, 2023

Fast Company Selects Vivos Therapeutics for 2022

“World’s Most Innovative Companies” List

Read More

Corporate Leadership

Our leadership team is devoted to a singular mission: to rid the world of sleep apnea.

Meet Our Leadership Team


Patients Treated


Doctors Integrated + Trained


Over 1 Billion Potential Patients

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign Up Now

Investor Relations Contacts

Home Office

Vivos Therapeutics, Inc.
(866) 908-4867
7921 Southpark Plaza
Suite 210
Littleton, CO

Investor Relations

Julie Gannon
Investment Relations Officer
(720) 442-8113
7921 Southpark Plaza
Suite 210
Littleton, CO

Phil Carlson / Scott Eckstein
KCSA Strategic Communications
(212) 896-1210

Transfer Agent

Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Fax: (646) 536-3179